Your browser doesn't support javascript.
loading
Identification of Tumor Antigens Among the HLA Peptidomes of Glioblastoma Tumors and Plasma.
Shraibman, Bracha; Barnea, Eilon; Kadosh, Dganit Melamed; Haimovich, Yael; Slobodin, Gleb; Rosner, Itzhak; López-Larrea, Carlos; Hilf, Norbert; Kuttruff, Sabrina; Song, Colette; Britten, Cedrik; Castle, John; Kreiter, Sebastian; Frenzel, Katrin; Tatagiba, Marcos; Tabatabai, Ghazaleh; Dietrich, Pierre-Yves; Dutoit, Valérie; Wick, Wolfgang; Platten, Michael; Winkler, Frank; von Deimling, Andreas; Kroep, Judith; Sahuquillo, Juan; Martinez-Ricarte, Francisco; Rodon, Jordi; Lassen, Ulrik; Ottensmeier, Christian; van der Burg, Sjoerd H; Thor Straten, Per; Poulsen, Hans Skovgaard; Ponsati, Berta; Okada, Hideho; Rammensee, Hans-Georg; Sahin, Ugur; Singh, Harpreet; Admon, Arie.
  • Shraibman B; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel.
  • Barnea E; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel.
  • Kadosh DM; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel.
  • Haimovich Y; From the ‡Department of Biology, Technion, Israel Institute of Technology, Haifa 32000, Israel.
  • Slobodin G; §Rheumatology Unit, Bnai Zion Medical Center, Haifa 31048, Israel.
  • Rosner I; §Rheumatology Unit, Bnai Zion Medical Center, Haifa 31048, Israel.
  • López-Larrea C; ¶Hospital Universitario Central de Asturias, 33011 Oviedo, Asturias, Spain.
  • Hilf N; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany.
  • Kuttruff S; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany.
  • Song C; ‖Immatics Biotechnologies GmbH, Paul-Ehrlich-Str. 15,72076 Tuebingen, Germany.
  • Britten C; **BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.
  • Castle J; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany.
  • Kreiter S; **BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.
  • Frenzel K; **BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.
  • Tatagiba M; **BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.
  • Tabatabai G; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany.
  • Dietrich PY; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany.
  • Dutoit V; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland.
  • Wick W; §§Université de Genève, Rue Gabrielle Perret Gentil 4; 1211 Geneve 14, Switzerland.
  • Platten M; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany.
  • Winkler F; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany.
  • von Deimling A; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany.
  • Kroep J; ¶¶Heidelberg University Medical Center, Im Neuenheimer Feld 672, D-69120 Heidelberg, Germany.
  • Sahuquillo J; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Martinez-Ricarte F; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
  • Rodon J; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
  • Lassen U; ‡‡‡Vall d'Hebron University Hospital, Institut Catala de la Salut, Pg. Vall d'Hebron 119-129, 08035 Barcelona, Spain.
  • Ottensmeier C; ‖‖‖Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark.
  • van der Burg SH; §§§Cancer Sciences Division, Faculty of Medicine, University of Southampton, Southampton, UK.
  • Thor Straten P; ‖‖Leiden University Medical Center, Department of Medical Oncology, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
  • Poulsen HS; ¶¶¶Association for Cancer Immunotherapy (CIMT), Langenbeckstr. 1,55131 Mainz, Germany.
  • Ponsati B; ‖‖‖Region Hovedstaden (Center for Cancer Immune Therapy (CCIT), Herlev Hospital, Herlev Ringvej 75, DK-2730, Copenhagen, Denmark.
  • Okada H; ‡‡‡‡Rigshospitalet, Departments of Radiation Biology and Oncology, Rigshospitalet 9, Blegdamsvej, DK-2100, Copenhagen, Denmark.
  • Rammensee HG; §§§§BCN Peptides, Pol. Ind. Els Vinyets-Els Fogars II. 08777 Sant Quinti de Mediona (Barcelona), Spain.
  • Sahin U; ¶¶¶¶University of California and the Parker Institute for Cancer Immunotherapy, San Francisco, CA 94131.
  • Singh H; ‡‡Eberhard Karls Universität Tübingen, Department of Immunology, Auf der Morgenstelle 15,72076 Tubingen, Germany.
  • Admon A; **BioNTech AG, Holderlinstr. 8,55131 Mainz, Germany.
Mol Cell Proteomics ; 18(6): 1255-1268, 2019 06.
Article en En | MEDLINE | ID: mdl-31154438
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Neoplasias Encefálicas / Antígenos de Histocompatibilidad Clase I / Glioblastoma / Proteoma / Antígenos de Neoplasias Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Péptidos / Neoplasias Encefálicas / Antígenos de Histocompatibilidad Clase I / Glioblastoma / Proteoma / Antígenos de Neoplasias Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Año: 2019 Tipo del documento: Article